title: The practical management of haemophilia.
abstract: Haemophilia is a rare and complex disorder and its successful management will depend upon the establishment of a network of 'comprehensive care' including the services of haematologists, orthopaedic surgeons, rheumatologists, dental surgeons, physiotherapists, specialised nurses and counsellors. One of the major lessons to be learned from the HIV epidemic in haemophilia is that it is critical to strive to obtain the safest and purest forms of blood products for these patients. The advent of clinically available recombinant factor VIII is expected soon; in the meantime there is a move towards treating all patients with high purity products.
authors.affiliation: East Kent Haemophilia Centre, Thanet District Hospital, Margate, Kent, UK.
authors.forename: M
authors.initials: M
authors.lastname: Winter
mesh_terms: D002543:Cerebral Hemorrhage / Q000209:etiology / Q000517:prevention & control; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D005164:Factor IX / Q000276:immunology / Q000627:therapeutic use; D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use; D005817:Genetic Counseling; D006395:Hemarthrosis / Q000209:etiology / Q000517:prevention & control; D006467:Hemophilia A / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D002836:Hemophilia B / Q000628:therapy; D006801:Humans; D008297:Male; D010348:Patient Care Team; D015995:Prevalence; D065227:Transfusion Reaction; D014777:Virus Diseases / Q000150:complications / Q000635:transmission; D014842:von Willebrand Diseases / Q000188:drug therapy / Q000628:therapy
chemical_list: D005169:Factor VIII; D005164:Factor IX; D003894:Deamino Arginine Vasopressin